Position in NTLA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$257,962
+$71,757 QoQ
Shares Held
15,246
+41.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#42
of 102 holders
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026R Squared Ltd holds $4,187,945 across 33 Biotechnology names. NTLA ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,337 | $664,128 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
902 | $562,433 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
5,313 | $421,267 | |
| 4 | MRNA |
Moderna, Inc.
|
5,647 | $395,459 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
This page
|
15,246 | $257,962 | |
| 6 | BLTE |
Belite Bio, Inc
|
1,338 | $206,031 | |
| 7 | CYTK |
Cytokinetics Inc
|
2,350 | $200,196 | |
| 8 | MESO |
Mesoblast Ltd
|
14,492 | $196,076 |
All Filings in NTLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $257,962 | 15,246 | Shares | Sole | 2026-08-05 | |
| 2025-09-30 | $186,205 | 10,782 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $19,005 | 1,630 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||